Status:
COMPLETED
Pandemic Triage Score in Patients With Known or Suspected Severe Acute Respiratory Syndrome (SARS) CoronaVirus (CoV) 2 Infection
Lead Sponsor:
Groupe Hospitalier de la Rochelle Ré Aunis
Collaborating Sponsors:
NumaHealth International
Conditions:
SARS-CoV-2 Acute Respiratory Disease
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
During this pandemic period, the goal of the health care system is to optimize the use of intensive care services for patients infected with SARS-CoV-2, given the frequency of complications that can l...
Detailed Description
The body undergoes a systemic adaptation response to severe illness. Elevated cortisol and systemic inflammation are two key responses. Along with hypotension, this triad can lead to end-organ failure...
Eligibility Criteria
Inclusion
- Patient with clinical signs of CoV-2-SARS infection
- Complete blood count test and systolic blood pressure available at the time of diagnosis
- Informed of the study.
Exclusion
- Women beyond the 1st trimester of pregnancy
- Persons under-the-age-of or legally-denied medical decision-making capacity by a judicial or administrative decision,
- Persons of full age who are subject to a legal protection measure,
- Persons unable to consent,
- Persons who are not members of or beneficiaries of a social welfare program administered by the Republic of France
- Patient's refusal to participate in the study.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2020
Estimated Enrollment :
91 Patients enrolled
Trial Details
Trial ID
NCT04371471
Start Date
March 1 2020
End Date
April 30 2020
Last Update
July 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier de la Rochelle Ré Aunis
La Rochelle, France